Skip to Main Content

Paper Details

Molecular Modeling and Functional Analysis of Exome Sequencing-Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma.
JCO Precis Oncol
6
2017
Cholangiocarcinoma, ERK, F276C, FGFR, FGFR2, FGFR2 F276C, FGFR2 Mutant, FGFR4, G539R, KDR, R78H, VUS, VUSs, gene coding regions, oncologists, patient, receptor, receptor tyrosine kinase, receptortyrosine kinase, tumor, tumors, tyrosine, variant sequence, wild-type counterpart
Author NameAffiliation
Jean-Pierre A KocherMayo Clinic, University of Georgia
Naresh ProdduturiMayo Clinic, University of Georgia
Alan H BryceMayo Clinic, University of Georgia
Thai H HoMayo Clinic, University of Georgia
Richard W JosephMayo Clinic, University of Georgia
Amulya A Nageswara RaoMayo Clinic, University of Georgia
Sameer A ParikhMayo Clinic, University of Georgia
Jennifer B McCormickMayo Clinic, University of Georgia
Robert W WilliamsMayo Clinic, University of Georgia
Robert W WilliamsMayo Clinic, University of Georgia
Eric D WiebenMayo Clinic, University of Georgia
Konstantinos N LazaridisMayo Clinic, University of Georgia
Gianrico FarrugiaMayo Clinic, University of Georgia
Alexander Keith StewartMayo Clinic, University of Georgia
Eric W KleeMayo Clinic, University of Georgia
  • 1 - 15

Datasets

Release 1.2